Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Immuno-neurology targets immune dysfunction as a cause of multiple pathologi... Read more
45 minutes ago
MarketWatch
49 minutes ago
Yahoo
49 minutes ago
MarketWatch
1 hour ago
Yahoo
More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.